Detalhe da pesquisa
1.
Androgen receptor activity in T cells limits checkpoint blockade efficacy.
Nature
; 606(7915): 791-796, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35322234
2.
Restored Thymic Output after Androgen Blockade Participates in Antitumor Immunity.
J Immunol
; 210(4): 496-503, 2023 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36548468
3.
PD-1-specific "Blocking" antibodies that deplete PD-1+ T cells present an inconvenient variable in preclinical immunotherapy experiments.
Eur J Immunol
; 51(6): 1473-1481, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33684223
4.
OX40 Agonist Tumor Immunotherapy Does Not Impact Regulatory T Cell Suppressive Function.
J Immunol
; 203(7): 2011-2019, 2019 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31434709
5.
The Relationship Between Checkpoint Inhibitors and the Gut Microbiome and Its Application in Prostate Cancer.
Oncology (Williston Park)
; 34(3)2020 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-32212131
6.
Nod2 Deficiency Augments Th17 Responses and Exacerbates Autoimmune Arthritis.
J Immunol
; 201(7): 1889-1898, 2018 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30150283
7.
Immunotherapy Expands and Maintains the Function of High-Affinity Tumor-Infiltrating CD8 T Cells In Situ.
J Immunol
; 197(6): 2509-21, 2016 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27503208
8.
Treg cells meet their limit.
Nat Immunol
; 10(6): 565-6, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19448655
9.
B-Raf is required for positive selection and survival of DP cells, but not for negative selection of SP cells.
Int Immunol
; 25(4): 259-69, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23334952
10.
PD-1 Limits IL-2 Production and Thymic Regulatory T Cell Development.
Immunohorizons
; 8(3): 281-294, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38551395
11.
Thymic expression of immune checkpoint molecules and their implication for response to immunotherapies.
Trends Cancer
; 9(8): 666-678, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37173189
12.
T-cell receptor affinity in thymic development.
Immunology
; 135(4): 261-7, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22182461
13.
Composition of gastrointestinal microbiota in association with treatment response in individuals with metastatic castrate resistant prostate cancer progressing on enzalutamide and initiating treatment with anti-PD-1 (pembrolizumab).
Neoplasia
; 32: 100822, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35908379
14.
Identifying phenotype-associated subpopulations by integrating bulk and single-cell sequencing data.
Nat Biotechnol
; 40(4): 527-538, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34764492
15.
Supporting the Next Generation of Scientists to Lead Cancer Immunology Research.
Cancer Immunol Res
; 9(11): 1245-1251, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34544686
16.
Phase II Study of Ipilimumab in Men With Metastatic Prostate Cancer With an Incomplete Response to Androgen Deprivation Therapy.
Front Oncol
; 10: 1381, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32850444
17.
A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide alone.
J Immunother Cancer
; 8(2)2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32616555
18.
Late-Stage Tumor Regression after PD-L1 Blockade Plus a Concurrent OX40 Agonist.
Cancer Immunol Res
; 7(2): 269-281, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30563828
19.
Changes in antitumor response in C57BL/6J-Min/+ mice during long-term administration of a selective cyclooxygenase-2 inhibitor.
Cancer Res
; 66(12): 6432-8, 2006 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16778222
20.
Carnosol inhibits beta-catenin tyrosine phosphorylation and prevents adenoma formation in the C57BL/6J/Min/+ (Min/+) mouse.
Cancer Res
; 65(3): 1097-104, 2005 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15705912